{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:23:52Z","timestamp":1791699832164,"version":"4.3.4"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ccm.2016.12.006","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T04:15:36Z","timestamp":1493871336000},"page":"279-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Fungal Pneumonia in\u00a0Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"38","author":[{"given":"Steven A.","family":"Pergam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ccm.2016.12.006_bib1","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S1470-2045(15)00389-7","article-title":"Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial","volume":"16","author":"Gay","year":"2015","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.ccm.2016.12.006_bib2","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.23388","article-title":"The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole","volume":"88","author":"Barreto","year":"2013","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/myc.12318","article-title":"Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens","volume":"58","author":"Corzo-Leon","year":"2015","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation","volume":"47","author":"Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib12","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","article-title":"Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study\u2013Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne","volume":"45","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","author":"Mariette","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ccm.2016.12.006_bib17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2015.181","article-title":"Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis","volume":"50","author":"Montesinos","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib18","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1093\/jac\/dkw199","article-title":"A\u00a0cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis","volume":"71","author":"Biehl","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s15010-007-6350-2","article-title":"Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome","volume":"35","author":"Gil","year":"2007","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.01525-13","article-title":"Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011","volume":"58","author":"Gomes","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ccm.2016.12.006_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.11478","article-title":"Infections in patients with aplastic anemia: experience at a tertiary care cancer center","volume":"98","author":"Torres","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0609.2012.01770.x","article-title":"Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy","volume":"88","author":"Quarello","year":"2012","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib24","doi-asserted-by":"crossref","first-page":"490.e1-10","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib25","first-page":"331","article-title":"Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009","volume":"60","author":"Campo","year":"2010","journal-title":"J\u00a0Infect"},{"issue":"13","key":"10.1016\/j.ccm.2016.12.006_bib26","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/myc.12149","article-title":"Prospective antifungal therapy (PATH) Alliance\u00ae: focus on mucormycosis","volume":"57","author":"Kontoyiannis","year":"2014","journal-title":"Mycoses"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2016.12.006_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/mmy\/myv018","article-title":"Phaeohyphomycosis in transplant recipients: results from the Transplant Associated Infection Surveillance Network (TRANSNET)","volume":"53","author":"McCarty","year":"2015","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/myc.12344","article-title":"Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009)","volume":"58","author":"Klingspor","year":"2015","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tid.12186","article-title":"Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"16","author":"Kauffman","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib32","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jac\/dkw155","article-title":"Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Cordonnier","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2016.12.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2000.02014.x","article-title":"Towards a targeted, risk-based, antifungal strategy in neutropenic patients","volume":"110","author":"Prentice","year":"2000","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib36","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bmt.2009.383","article-title":"Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload","volume":"45","author":"Ozyilmaz","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"10.1016\/j.ccm.2016.12.006_bib37","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa0802629","article-title":"Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation","volume":"359","author":"Bochud","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib38","doi-asserted-by":"crossref","first-page":"e32273","DOI":"10.1371\/journal.pone.0032273","article-title":"Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary aspergillosis infection","volume":"7","author":"Sainz","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib39","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/644619","article-title":"Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients","volume":"49","author":"Lambourne","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1055\/s-0031-1295723","article-title":"Pulmonary coccidioidomycosis","volume":"32","author":"Thompson","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.idc.2006.07.002","article-title":"Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis","volume":"20","author":"Kauffman","year":"2006","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11046-009-9247-z","article-title":"Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients","volume":"168","author":"Partridge-Hinckley","year":"2009","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/civ297","article-title":"Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation","volume":"61","author":"Kanamori","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib45","first-page":"819","article-title":"Inhaled medicinal cannabis and the immunocompromised patient","volume":"23","author":"Ruchlemer","year":"2015","journal-title":"Support Care Cancer"},{"issue":"22","key":"10.1016\/j.ccm.2016.12.006_bib46","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1001\/jama.284.22.2869","article-title":"Fungal contamination of tobacco and marijuana","volume":"284","author":"Verweij","year":"2000","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib47","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2016.12.006_bib49","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1086\/320524","article-title":"Cryptococcosis in patients with cancer","volume":"32","author":"Kontoyiannis","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","article-title":"Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ccm.2016.12.006_bib51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib52","first-page":"862","article-title":"Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program","volume":"86","author":"Pagano","year":"2001","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MD.0b013e31826c2ccf","article-title":"Aspergillus tracheobronchitis: report of 8 cases and review of the literature","volume":"91","author":"Fernandez-Ruiz","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QCO.0b013e328348b2e1","article-title":"Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients","volume":"24","author":"Marom","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2016.12.006_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib56","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(97)89455-7","article-title":"The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis","volume":"100","author":"Horvath","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/tid.12211","article-title":"Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis","volume":"16","author":"Fisher","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib59","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1309\/EXBVYAUPENBM285Y","article-title":"Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination","volume":"119","author":"Tarrand","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.ccm.2016.12.006_bib60","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1704793","article-title":"What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience","volume":"35","author":"Simoneau","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4161\/viru.2.2.15015","article-title":"The challenge of managing fusariosis","volume":"2","author":"Muhammed","year":"2011","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.ccm.2016.12.006_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00027-06","article-title":"Histoplasmosis: a clinical and laboratory update","volume":"20","author":"Kauffman","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib64","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, beta-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/mmy\/myv026","article-title":"The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients","volume":"53","author":"Ambasta","year":"2015","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib66","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib67","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6\u20137","key":"10.1016\/j.ccm.2016.12.006_bib68","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365541003602064","article-title":"False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics","volume":"42","author":"Boonsarngsuk","year":"2010","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib69","first-page":"233","article-title":"Multiple myeloma as a major cause of false-positive galactomannan tests in adult patients with cancer","volume":"72","author":"Ko","year":"2016","journal-title":"J\u00a0Infect"},{"issue":"7","key":"10.1016\/j.ccm.2016.12.006_bib70","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cit393","article-title":"The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"57","author":"Fisher","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib71","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2141.2003.04308.x","article-title":"Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis","volume":"121","author":"Becker","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib72","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1128\/JCM.05026-11","article-title":"Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay","volume":"49","author":"Torelli","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib73","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2014.03.020","article-title":"Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies","volume":"79","author":"Heng","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib74","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.md.0000126762.91040.fd","article-title":"Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies","volume":"83","author":"Crum","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib76","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10096-008-0529-z","article-title":"Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease","volume":"27","author":"Baddley","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009551.pub2","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","author":"Cruciani","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib79","first-page":"206","article-title":"Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway","volume":"67","author":"Barnes","year":"2013","journal-title":"J\u00a0Infect"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib80","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay\u00ae in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib81","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/JCM.00637-14","article-title":"Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis","volume":"52","author":"Lengerova","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib82","doi-asserted-by":"crossref","first-page":"810.e1-8","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib83","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib84","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cid\/ciu725","article-title":"A\u00a0breath fungal secondary metabolite signature to diagnose invasive aspergillosis","volume":"59","author":"Koo","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib85","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib86","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.bbmt.2016.08.023","article-title":"Decline in the use of surgical biopsy for diagnosis of pulmonary disease in hematopoietic cell transplantation recipients in an era of improved diagnostics and empirical therapy","volume":"22","author":"Cheng","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib87","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.diii.2012.12.008","article-title":"CT-guided biopsies in lung infections in patients with haematological malignancies","volume":"94","author":"de Bazelaire","year":"2013","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib88","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.athoracsur.2009.02.069","article-title":"Surgical management of invasive pulmonary fungal infection in hematology patients","volume":"87","author":"Theodore","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib89","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bmt.1705505","article-title":"Retrospective utility of bronchoscopy after hematopoietic stem cell transplant","volume":"38","author":"Hofmeister","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib90","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib91","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/AJCP99OOOZSNISCZ","article-title":"Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution","volume":"131","author":"Sangoi","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib92","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib93","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciu911","volume":"60","author":"Herbrecht","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib94","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib95","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bbmt.2015.10.021","article-title":"Correlation of pain and fluoride concentration in allogeneic hematopoietic stem cell transplant recipients on voriconazole","volume":"22","author":"Barajas","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.ccm.2016.12.006_bib96","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389200215666141125121511","article-title":"Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450","volume":"15","author":"Niwa","year":"2014","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib97","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2217\/pgs.11.18","article-title":"Pharmacogenomics of the triazole antifungal agent voriconazole","volume":"12","author":"Mikus","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib98","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10020","key":"10.1016\/j.ccm.2016.12.006_bib99","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ccm.2016.12.006_bib100","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib101","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Baddley","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3201\/eid1203.050670","article-title":"Aspergillus ustus infections among transplant recipients","volume":"12","author":"Panackal","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2016.12.006_bib103","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1473-3099(16)30138-4","article-title":"In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management","volume":"16","author":"Verweij","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.ccm.2016.12.006_bib104","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","author":"Verweij","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib105","first-page":"453","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J\u00a0Infect"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib106","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib107","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/591531","article-title":"Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study","volume":"47","author":"Slobbe","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2016.12.006_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib109","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2016.12.006_bib110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib111","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2016.12.006_bib112","first-page":"1","article-title":"Pharmacokinetics and safety of\u00a0posaconazole delayed-release tablets for invasive fungal infections","volume":"8","author":"Wiederhold","year":"2016","journal-title":"Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.ccm.2016.12.006_bib113","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib114","doi-asserted-by":"crossref","first-page":"811.e1-8","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2016.12.006_bib115","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how?","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib116","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib117","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10096-013-1924-7","article-title":"Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment","volume":"32","author":"Guarro","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib118","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib119","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole treatment of cryptococcosis and dimorphic mycoses","volume":"63","author":"Thompson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/myc.12496","article-title":"Cryptococcus neoformans infection in malignancy","volume":"59","author":"Schmalzle","year":"2016","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.ccm.2016.12.006_bib121","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib122","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1086\/588300","article-title":"Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America","volume":"46","author":"Chapman","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2016.12.006_bib123","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.12.006_bib124","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1399-3062.2007.00203.x","article-title":"Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient","volume":"9","author":"Tong","year":"2007","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib125","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1128\/AAC.00145-15","article-title":"In\u00a0vitro triple combination of antifungal drugs against clinical Scopulariopsis and Microascus species","volume":"59","author":"Yao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib126","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib127","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.ccm.2016.12.006_bib128","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ccm.2016.12.006_bib129","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/civ555","article-title":"Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis","volume":"61","author":"Arvanitis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2016.12.006_bib130","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2016.12.006_bib131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib132","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2016.12.006_bib133","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2010.04.017","article-title":"Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients","volume":"17","author":"Winston","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ccm.2016.12.006_bib134","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.ccm.2016.12.006_bib135","doi-asserted-by":"crossref","first-page":"O952","DOI":"10.1111\/1469-0691.12688","article-title":"Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study","volume":"20","author":"Lerolle","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ccm.2016.12.006_bib136","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12185-008-0196-y","article-title":"Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation","volume":"88","author":"Hiramatsu","year":"2008","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib137","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2016.12.006_bib138","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinthera.2013.11.010","article-title":"Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis","volume":"36","author":"Ziakas","year":"2014","journal-title":"Clin Ther"},{"issue":"No. RR-10","key":"10.1016\/j.ccm.2016.12.006_bib139","first-page":"1","article-title":"Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.ccm.2016.12.006_bib140","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ccm.2016.12.006_bib141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/501967","article-title":"Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction","volume":"23","author":"Raad","year":"2002","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523116301411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523116301411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:55:24Z","timestamp":1759452924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523116301411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0272523116301411"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2016.12.006","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fungal Pneumonia in\u00a0Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}